Literature DB >> 21856021

Response of proinflammatory and anti-inflammatory cytokines in calves with subclinical bovine viral diarrhea challenged with bovine herpesvirus-1.

M A Risalde1, V Molina, P J Sánchez-Cordón, M Pedrera, R Panadero, F Romero-Palomo, J C Gómez-Villamandos.   

Abstract

The aim of this work was to investigate the susceptibility of calves infected with bovine viral diarrhea virus (BVDV) against secondary infections. For this purpose, the profile of cytokines implicated in the immune response of calves experimentally infected with a non-cytopathic strain of BVDV type-1 and challenged with bovine herpesvirus 1.1 (BHV-1.1) was evaluated in comparison with healthy animals challenged only with BHV-1.1. The immune response was measured by serum concentrations of cytokines (IL-1β, TNFα, IFNγ, IL-12, IL-4 and IL-10), acute phase proteins (haptoglobin, serum amyloid A and fibrinogen) and BVDV and BHV-1.1 specific antibodies. BVDV-infected calves displayed a great secretion of TNFα and reduced production of IL-10 following BHV-1 infection, leading to an exacerbation of the inflammatory response and to the development of more intense clinical symptoms and lesions than those observed in healthy animals BHV-1-inoculated. A Th1 immune response, based on IFNγ production and on the absence of significant changes in IL-4 production, was observed in both groups of BHV-1-infected calves. However, whereas the animals inoculated only with BHV-1 presented an IFNγ response from the start of the study and high expression of IL-12, the BVDV-infected calves showed a delay in the IFNγ production and low levels of IL-12. This alteration in the kinetic and magnitude of these cytokines, involved in cytotoxic mechanisms responsible for limiting the spread of secondary pathogens, facilitated the dissemination of BHV-1.1 in BVDV-infected calves.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856021     DOI: 10.1016/j.vetimm.2011.07.022

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  In Vitro and In Vivo Characterization of a Typical and a High Pathogenic Bovine Viral Diarrhea Virus Type II Strains.

Authors:  Dario Amilcar Malacari; Andrea Pécora; Maria Sol Pérez Aguirreburualde; Nancy Patricia Cardoso; Anselmo Carlos Odeón; Alejandra Victoria Capozzo
Journal:  Front Vet Sci       Date:  2018-04-13

2.  The Involvement of Histone H3 Acetylation in Bovine Herpesvirus 1 Replication in MDBK Cells.

Authors:  Liqian Zhu; Xinyi Jiang; Xiaotian Fu; Yanhua Qi; Guoqiang Zhu
Journal:  Viruses       Date:  2018-09-27       Impact factor: 5.048

3.  Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses.

Authors:  Chun-Yu Liu; Hao Guo; Hong-Zhe Zhao; Li-Na Hou; Yong-Jun Wen; Feng-Xue Wang
Journal:  Viruses       Date:  2022-07-25       Impact factor: 5.818

Review 4.  Understanding the mechanisms of viral and bacterial coinfections in bovine respiratory disease: a comprehensive literature review of experimental evidence.

Authors:  Maria Gaudino; Brandy Nagamine; Mariette F Ducatez; Gilles Meyer
Journal:  Vet Res       Date:  2022-09-06       Impact factor: 3.829

5.  Pathogenic mechanisms implicated in the intravascular coagulation in the lungs of BVDV-infected calves challenged with BHV-1.

Authors:  María A Risalde; Verónica Molina; Pedro J Sánchez-Cordón; Fernando Romero-Palomo; Miriam Pedrera; Bartolomé Garfia; José C Gómez-Villamandos
Journal:  Vet Res       Date:  2013-03-18       Impact factor: 3.683

6.  Complete genome sequence and pathogenesis of bovine viral diarrhea virus JL-1 isolate from cattle in China.

Authors:  Shuqin Zhang; Bin Tan; Yulin Ding; Fengxue Wang; Li Guo; Yongjun Wen; Shipeng Cheng; Hua Wu
Journal:  Virol J       Date:  2014-04-08       Impact factor: 4.099

7.  The role of phospholipase C signaling in bovine herpesvirus 1 infection.

Authors:  Liqian Zhu; Chen Yuan; Xiuyan Ding; Clinton Jones; Guoqiang Zhu
Journal:  Vet Res       Date:  2017-09-07       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.